Abstract
Aim. To determine the effectiveness of minimally invasive personalized surgical treatment of submacular hemorrhages (SMH) against the background of neovascular age-related macular degeneration (nАMD). Methods. The data of 77 people (77 eyes) were processed in the study. Of these, 36 eyes had a small hemorrhage size, 22 had an average size, massive size was seen in 19 patients. Results. A minimally invasive personalized approach to the treatment of subfoveal hemorrhages of various sizes has been proposed and applied. Conclusion. Improvement of vision with an appropriate treatment strategy is regardless of the size of the SMH. After performing vitreoretinal intervention, subsequent therapy with angiogenesis inhibitors is required, in accordance with the etiological factor. Key words: submacular hemorrhage; fibrinolytic; pneumodislocation; age-related macular degeneration.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
